The Latest Analyst Ratings for NextGen Healthcare
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinions on NextGen Healthcare (NASDAQ:NXGN) stock, with an average price target of $21.0, implying upside from the current price of $15.77. The current average has decreased by 7.37% from the previous average price target of $22.67.
May 23, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
5 analysts have rated NextGen Healthcare (NASDAQ:NXGN) stock with an average price target of $21.0, implying upside from the current price of $15.77.
The average price target of $21.0 by 5 analysts implies an upside potential for NextGen Healthcare's stock. This is a positive signal for investors, as it indicates that analysts believe the stock has room to grow. The decrease in the average price target from $22.67 to $21.0 may indicate a slightly more cautious outlook, but the overall sentiment remains positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100